ASGE Annual GI Advanced Practice Provider Course (Virtual) - Clinical Case-Based Learning (Day Two)

ASGE_GHAPP NordICC Fact Sheet

Pdf Summary

The Nordic-European Initiative on Colorectal Cancer Trial (NordICC Trial) Fact Sheet provides key information about the effectiveness and importance of screening colonoscopy in preventing colorectal cancer. The fact sheet highlights that screening colonoscopy saves lives by detecting and removing adenomas and early cancers during the same procedure. It emphasizes that colonoscopy is the only colorectal cancer screening test that both detects and eliminates these abnormalities.<br /><br />One important finding of the NordICC trial is that only 42% of participants who were invited to undergo screening colonoscopy actually did so. This emphasizes the importance of actually performing the procedure for it to be effective. The trial also estimated that colonoscopy reduced the incidence of colorectal cancer by 31% and the risk of death from colorectal cancer by 50%.<br /><br />The fact sheet also emphasizes that the effectiveness of colonoscopy is highly dependent on the operator. It states that nearly 30% of endoscopists in the trial did not meet the recommended adenoma detection rate (ADR) of 25%, with the average ADR in the US being 40%. Studies have shown that a higher ADR is associated with a lower risk of colorectal cancer.<br /><br />For patients, the fact sheet provides important information about the screening and surveillance strategies for different risk groups. It highlights that patients with a family history of colon cancer and/or advanced adenomas, certain hereditary syndromes, or personal history of colon adenomas or cancer should discuss the appropriate screening options with their gastroenterologist.<br /><br />The fact sheet also provides information for healthcare providers, emphasizing the importance of ADR and the impact it has on reducing the future incidence of colorectal cancer and CRC-related death. It also advises referral for colonoscopy for patients who test positive on stool-based FIT or DNA tests.<br /><br />Overall, the fact sheet emphasizes the effectiveness of screening colonoscopy in preventing colorectal cancer and the importance of proper screening strategies tailored to individual patient risk factors.

Keywords

NordICC Trial

screening colonoscopy

colorectal cancer prevention

adenoma detection rate

importance of procedure performance

incidence of colorectal cancer

risk of death from colorectal cancer

surveillance strategies for risk groups

healthcare provider referral

stool-based FIT and DNA tests